Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000035542 | SCV000052954 | likely benign | not specified | 2023-10-02 | criteria provided, single submitter | clinical testing | Variant summary: MYBPC3 c.2914C>T (p.Arg972Trp) results in a non-conservative amino acid change located in the Immunoglobulin-like domain (IPR007110) of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00023 in 185800 control chromosomes, predominantly at a frequency of 0.0037 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 3.7-fold of the estimated maximal expected allele frequency for a pathogenic variant in MYBPC3 causing Cardiomyopathy phenotype (0.001), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.2914C>T has been reported in the literature in individuals affected with Cardiomyopathy without strong evidence of causality (Bick_2012, Burstein_2021). These reports do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22958901, 32746448). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as likely benign. |
Laboratory for Molecular Medicine, |
RCV000035542 | SCV000059192 | benign | not specified | 2022-03-23 | criteria provided, single submitter | clinical testing | The p.Arg972Trp variant in MYBPC3 is classified as benign because it has been identified in 0.3% (58/18682) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org). In addition, one mammalian species (elephant) carries a tryptophan at this position, despite high nearby amino acid conservation, further supporting a benign role. ACMG/AMP Criteria applied: BA1. |
Gene |
RCV001529595 | SCV000207991 | likely benign | not provided | 2021-04-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22958901) |
Ambry Genetics | RCV000245670 | SCV000318294 | likely benign | Cardiovascular phenotype | 2018-08-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000466462 | SCV000546448 | likely benign | Hypertrophic cardiomyopathy | 2024-01-20 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770332 | SCV000901766 | benign | Cardiomyopathy | 2023-05-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000035542 | SCV001157731 | likely benign | not specified | 2019-03-03 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000770332 | SCV001353201 | likely benign | Cardiomyopathy | 2018-11-30 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529595 | SCV001743294 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001529595 | SCV001919942 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529595 | SCV001955628 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529595 | SCV001967173 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000466462 | SCV003800598 | benign | Hypertrophic cardiomyopathy | 2022-10-10 | no assertion criteria provided | clinical testing |